CompanyTrack
M

MBS5 LIMITED

Active London

Research and experimental development on biotechnology

0 employees
Research and experimental development on biotechnology
M

MBS5 LIMITED

Research and experimental development on biotechnology

Founded 18 May 2018 Active London, United Kingdom 0 employees
Research and experimental development on biotechnology
Accounts Submitted 15 Sept 2025
Confirmation Statement Submitted 28 May 2025
Net assets £-53.88K £0.00 2024 year on year
Total assets £186.81K £9.31K 2024 year on year
Total Liabilities £240.69K £9.31K 2024 year on year
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

2nd Floor 3 Pancras Square Kings Cross London N1C 4AG United Kingdom

Credit Report

Discover MBS5 LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£186.71k

Net Assets

-£53.88k

Total Liabilities

£240.69k

Decreased by £9.31k (-4%)

Turnover

N/A

Employees

N/A

Debt Ratio

129%

Increased by 2 (+2%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

3 active
Status
Lisa PatelDirectorBritishUnited Kingdom5227 Jan 2022Active
Pinsent Masons Secretarial LimitedCorporate-secretaryUnited KingdomUnknown18 May 2018Active
Samuel Cameron WilliamsDirectorBritishUnited Kingdom5618 May 2018Active

Shareholders

Shareholders (1)

Istesso Limited
100.0%
120 May 2019

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Istesso Limited

United Kingdom

Active
Notified 18 May 2018
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

ISTESSO LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent
IP2IPO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
IP GROUP PLC united kingdom
MBS5 LIMITED Current Company

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
15 Sept 2025AccountsAnnual accounts made up to 2024-12-31View(11 pages)
28 May 2025Confirmation StatementConfirmation statement made on 2025-05-17 with no updatesView(3 pages)
3 Jan 2025AccountsAnnual accounts made up to 2023-12-31View(11 pages)
4 Jun 2024Confirmation StatementConfirmation statement made on 2024-05-17 with no updatesView(3 pages)
10 Oct 2023AccountsAnnual accounts made up to 2022-12-31View(11 pages)
15 Sept 2025 Accounts

Annual accounts made up to 2024-12-31

28 May 2025 Confirmation Statement

Confirmation statement made on 2025-05-17 with no updates

3 Jan 2025 Accounts

Annual accounts made up to 2023-12-31

4 Jun 2024 Confirmation Statement

Confirmation statement made on 2024-05-17 with no updates

10 Oct 2023 Accounts

Annual accounts made up to 2022-12-31

Recent Activity

Latest Activity

Annual accounts made up to 2024-12-31

5 months ago on 15 Sept 2025

Confirmation statement made on 2025-05-17 with no updates

8 months ago on 28 May 2025

Annual accounts made up to 2023-12-31

1 years ago on 3 Jan 2025

Confirmation statement made on 2024-05-17 with no updates

1 years ago on 4 Jun 2024

Annual accounts made up to 2022-12-31

2 years ago on 10 Oct 2023